학술논문
Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
10970142